All children will be safe; children will get Zydus cadila vaccine from September
Children of 12 to 18 years in India may start getting Zydus cadila vaccine from September. Dr NK Arora, who heads the national expert group on vaccine administrative, has said during the interview that the third wave of Corona will have more impact on children. Amidst the apprehensions of this, there are relief signs that the results of the Zydus cadila vaccine trial on children are expected to be released before September.The Zydus cadila vaccine are free; the company is bringing an applicator to apply them. These have been developed by the company with Pharmajet , the Zydus cadila vaccine is a DNA vaccine that will be effective for Delta and all other variants .Bharat Biotech’s vaccine “Covaxin” may also be available for children in India soon. The Phase III trial of COVAXIN has started and is expected to be completed by the end of September. In such a situation, vaccination of children between 2 to 18 years can start in the country from October to December or mid-January February.
There is a huge epidemic regarding the opening of the school, which is Corona, during this epidemic, the schools of all the children have been closed for a long time. In such a situation, the government of India is doing its best to make every effort to make the future of the country bright. Meanwhile, the government has brought Zydus cadila vaccine for children. Dr. NK Arora who heads the national expert group on vaccine administratively has said that it is completely safe for children. And the vaccination will be given to children aged 12 to 18 years. The Zydus cadila vaccine will be the world’s first vaccine to require three doses. Zydus claims that antibodies have been found in up to 100 percent of children after taking a dose of Zydus cadila vaccine. The vaccine of Zydus cadila has been given to children and it is completely safe and with this it is the first vaccine in the country which has proved to be effective in children and while trials are being done on COVAXIN and Covishield.
